Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Lancet. Oncology|November 21, 2024
Preferences for speed of access versus certainty of the survival benefit of new cancer drugs: a discrete choice experimentRobin Forrest, Mylene Lagarde, Ajay Aggarwal, et al.
Gynecologic Oncology|December 14, 2011
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125Michèl Schummer, Charles Drescher, Robin Forrest, et al.
JAMA Network Open|June 9, 2026
Patient Perspectives on Approval Speed vs Evidentiary Certainty in US Cancer Drug ApprovalsRobin Forrest, Ajay Aggarwal, Michelle Tregear, et al.
Plos One|December 7, 2007
Effects of blood collection conditions on ovarian cancer serum markersJason D Thorpe, Xiaobo Duan, Robin Forrest, et al.
Clinical Pharmacology and Therapeutics|July 26, 2026
Navigating the Prescription Drug Information SystemIrina V Wang, Courtney Davis, Robin Forrest, et al.
Pageof 1